Dr. Shu-Yi Liao, DSC, MD, MPH, MS

Dr. Liao practices at National Jewish Health in Denver, Colorado, part of National Jewish Health.

Dr. Liao's NPI, 1740623404, was assigned on April 12, 2013. Dr. Liao graduated from Harvard Medical School in 2012. Dr. Liao holds Colorado license 62277.

Dr. Liao's primary practice is National Jewish Health, at 1400 Jackson St, Denver, CO 80206 in Denver County. The practice phone is (303) 388-4461.

Dr. Liao's primary practice is National Jewish Health in Denver, Colorado, part of National Jewish Health. Dr. Liao is also affiliated with Saint Joseph Hospital. The medical group on file is National Jewish Health. Dmand AI also links Dr. Liao to 1 more group practice or clinic and 1 medical group, each named with a free account. Dr. Liao's employer is on file too: a hospital.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Liao practices, 3 sites in all. Vendor and product names are available with a free account.

Pulmonary disease is Dr. Liao's primary specialty in the NPI Registry, under taxonomy code 207RP1001X. Dmand AI has Dr. Liao's licenses on file in 2 states: Colorado and California.

CMS data shows 83 Medicare services from Dr. Liao across 3 procedure codes in 2024, for 72 Medicare patients. Medicare paid $10,794 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 72 Medicare patients who saw Dr. Liao in 2024. The largest group is 65 to 74, with 38 patients. 71% of them have high cholesterol, and 61% have high blood pressure. 28% are also on Medicaid. Their average risk score is 2.20, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Liao's median patient age at 68, with 55% women.

In 2024, Dr. Liao wrote 148 Medicare Part D claims for 33 patients. 90% of them were for generic drugs. CMS names the drug for 104 of them, across 3 drugs with 11 or more claims each, at $6,523 in total drug cost. In 2023, CMS named 141 claims across 5 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 82 out of 100 for Dr. Liao for performance year 2024, reported as part of a group. Dr. Liao accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 45 papers to Dr. Liao, published from 2012 to 2025. 2014 was the busiest year, with 5. The most frequent topics are COVID-19, Genome-Wide Association Study and Sarcoidosis. Dr. Liao has published most often in ERJ Open Res. Dr. Liao's most frequent co-authors are Lisa M. Maier, MD, Barry J. Make, MD and Clara I. Restrepo, MD.

CMS Open Payments shows 5 general payments to Dr. Liao from 2 drug and device companies from 2021 to 2022. Food and beverage make up the largest share, 100% of the total. Regeneron Pharmaceuticals, Inc. paid the most, $130.

Dr. Liao graduated from Harvard Medical School in 2012.